Biogen Cash Flow from Operating Activities 2010-2025 | BIIB
Biogen cash flow from operating activities for the twelve months ending March 31, 2025 was $6.428B, a 40.44% increase year-over-year.
- Biogen annual cash flow from operating activities for 2024 was $2.876B, a 85.85% increase from 2023.
- Biogen annual cash flow from operating activities for 2023 was $1.547B, a 11.77% increase from 2022.
- Biogen annual cash flow from operating activities for 2022 was $1.384B, a 61.97% decline from 2021.